Home Former AbbVie Humira Business Director Gan Lijie Officially Departs

Former AbbVie Humira Business Director Gan Lijie Officially Departs

May 06, 2021 10:28 CST Updated 10:28
AbbVie

Innovative Drug Developer

According to the latest industry news, Gan Lijie, National Business Director of AbbVie’s Immunology Division, officially resigned before the May Day holiday to pursue external opportunities, with April 30 being his last working day.

According to available information, Gan Lijie majored in Accounting during his undergraduate studies. He joined Bayer Healthcare’s CC Division in 2002, where he was responsible for hospital sales of products such as Talcid and Canesten.

He subsequently joined Abbott Laboratories in 2010, advancing from Regional Manager to Area Manager, and later moved to Zambon Italy to oversee sales of respiratory products.

Joined AbbVie’s Immunology Division in 2017, responsible for Humira in the Eastern Region.

*Disclaimer: This article was written by an author contributing to Sina Medical News. The views expressed are solely those of the author and do not represent the position of Sina Medical News.